Adaptam Therapeutics
Donostia-san Sebastián
About Adaptam Therapeutics
Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.5M
- Funding stage: Seed
- Last round: Pre-Seed (Oct 2025)
- Website: adaptamtx.com
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/adaptam-therapeutics-69430 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.